Papers by Vasilios Athyros
JAMA: The Journal of …, Jan 1, 2007
Bookmarks Related papers MentionsView impact
Atherosclerosis, 2004
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Dermatology, 2007
ABSTRACT
Bookmarks Related papers MentionsView impact
The Open Hypertension Journal, 2013
Bookmarks Related papers MentionsView impact
Angiology, 2015
Bookmarks Related papers MentionsView impact
Journal of hepatology, Jan 6, 2015
Bookmarks Related papers MentionsView impact
Atherosclerosis Supplements, 2010
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Current Pharmaceutical Design
Bookmarks Related papers MentionsView impact
Hellenic journal of cardiology: HJC = Hellēnikē kardiologikē epitheōrēsē
Bookmarks Related papers MentionsView impact
Hellenic journal of cardiology: HJC = Hellēnikē kardiologikē epitheōrēsē
Bookmarks Related papers MentionsView impact
Angiology
We systematically reviewed the available data on carotid intima-media thickness (cIMT) in patient... more We systematically reviewed the available data on carotid intima-media thickness (cIMT) in patients with inflammatory bowel diseases (IBDs) without history of cardiovascular disease (CVD) and its associated factors. A total of 6 studies met the inclusion criteria including 217 patients with Crohn's disease (CD) and 85 with ulcerative colitis (UC). Two studies included only patients with CD. The prevalence of traditional CVD risk factors and the inflammatory burden (IBD duration and activity) varied greatly among patients and studies. Factors that correlated with cIMT were age, male gender, body mass index, arterial hypertension, as well as cholesterol and homocysteine levels. The current data on cIMT in patients with IBD are inconclusive. This is probably due to small number of patients, population heterogeneity with regard to inflammatory burden and smoking habits, and lack of strict matching with controls. In order to elucidate any potential association between IBD and CVD risk...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
The Open Hypertension Journal
Bookmarks Related papers MentionsView impact
The Open Hypertension Journal
Bookmarks Related papers MentionsView impact
Current Vascular Pharmacology, 2015
Bookmarks Related papers MentionsView impact
World journal of gastroenterology : WJG, Jan 7, 2015
To investigate the effect of rosuvastatin monotherapy on non-alcoholic steatohepatitis (NASH). At... more To investigate the effect of rosuvastatin monotherapy on non-alcoholic steatohepatitis (NASH). At present there is no effective treatment for non-alcoholic fatty liver disease or its advanced form NASH. This prospective study included 20 biopsy proven patients with NASH, metabolic syndrome (MetS) and dyslipidaemia. Biochemical parameters of the blood of the patients and an ultrasonography of the liver were performed at baseline. Then patients received lifestyle advice and were treated for a 12 mo period with rosuvastatin (10 mg/d) monotherapy. Patients were re-evaluated during the study at 3 mo intervals, during which biochemical parameters of the blood were measured including liver enzymes. A repeat biopsy and ultrasonography of the liver were performed at the end of the study in all 20 patients. Changes in liver enzymes, fasting plasma glucose, serum creatinine, serum uric acid (SUA), high sensitivity C reactive protein (hsCRP) and lipid profile were assessed every 3 mo. The prima...
Bookmarks Related papers MentionsView impact
Current Vascular Pharmacology
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Uploads
Papers by Vasilios Athyros